Jaseong Koo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jaseong Koo has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Taewon Kim
Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
3 shared publications - A Hyun Cho
The Catholic University of Korea
2 shared publications - Jinhee Jang
Department of Radiology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea
2 shared publications - Kijeong Lee
Department of Neurology, National Health Insurance Service Ilsan Hospital, Goyang, Korea
2 shared publications - Min Hwan Lee
Department of Neurology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea
2 shared publications - Seonghoon Kim
Department of Neurology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
2 shared publications
Latest Publications
- 12 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Longitudinal Inflammatory Trajectories and Recurrent Vascular Events After Acute Ischemic Stroke
Background: Inflammation contributes to the pathophysiology of acute ischemic stroke, yet no inflammatory biomarker has been established as a standard prognostic tool. Most prior studies have relied on single baseline measurements, and the prognostic relevance of longitudinal inflammatory changes remains uncertain. We investigated whether baseline levels and longitudinal trajectories of inflammatory burden index (IBI) and hs‐CRP (high‐sensitivity C‐reactive protein) are associated with recurrent stroke and major adverse cardiovascular events (MACE). Methods: In this prospective cohort study, 374 patients with acute ischemic stroke were analyzed. IBI was calculated as hs‐CRP multiplied by the neutrophil‐to‐lymphocyte ratio. Serum hs‐CRP and leukocyte differentials were measured within 24 hours of admission and at 6 months (±3 months). Baseline hs‐CRP was dichotomized at 2 mg/L and IBI at the median baseline value (4.03 mg/L), and longitudinal trajectories were defined as persistent low, increased, decreased, or persistent high based on changes between baseline and follow‐up measurements. Results: During a median follow‐up of 30.5 months, 58 patients (15.5%) experienced recurrent stroke and 69 (18.4%) experienced MACE. Baseline IBI and hs‐CRP showed inconsistent associations with these outcomes. In contrast, persistent high IBI was associated with increased risks of recurrent stroke (hazard ratio [HR] 2.46; 95% CI, 1.26–4.78; P =0.008) and MACE (HR 2.42; 95% CI, 1.33–4.43; P =0.004) compared with persistent low IBI. Persistent high hs‐CRP was associated with MACE (HR 1.92; 95% CI, 1.08–3.41; P =0.026) but not with recurrent stroke. Conclusions: Persistent high IBI trajectories were independently associated with recurrent stroke and MACE, and persistent high hs‐CRP trajectories were associated with MACE. Longitudinal assessment of inflammatory biomarkers may provide prognostic information beyond a single baseline measurement after ischemic stroke.
- 12 November 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
Longitudinal Inflammatory Trajectories and Recurrent Vascular Events After Acute Ischemic Stroke
Background: Inflammation contributes to the pathophysiology of acute ischemic stroke, yet no inflammatory biomarker has been established as a standard prognostic tool. Most prior studies have relied on single baseline measurements, and the prognostic relevance of longitudinal inflammatory changes remains uncertain. We investigated whether baseline levels and longitudinal trajectories of inflammatory burden index (IBI) and hs‐CRP (high‐sensitivity C‐reactive protein) are associated with recurrent stroke and major adverse cardiovascular events (MACE). Methods: In this prospective cohort study, 374 patients with acute ischemic stroke were analyzed. IBI was calculated as hs‐CRP multiplied by the neutrophil‐to‐lymphocyte ratio. Serum hs‐CRP and leukocyte differentials were measured within 24 hours of admission and at 6 months (±3 months). Baseline hs‐CRP was dichotomized at 2 mg/L and IBI at the median baseline value (4.03 mg/L), and longitudinal trajectories were defined as persistent low, increased, decreased, or persistent high based on changes between baseline and follow‐up measurements. Results: During a median follow‐up of 30.5 months, 58 patients (15.5%) experienced recurrent stroke and 69 (18.4%) experienced MACE. Baseline IBI and hs‐CRP showed inconsistent associations with these outcomes. In contrast, persistent high IBI was associated with increased risks of recurrent stroke (hazard ratio [HR] 2.46; 95% CI, 1.26–4.78; P =0.008) and MACE (HR 2.42; 95% CI, 1.33–4.43; P =0.004) compared with persistent low IBI. Persistent high hs‐CRP was associated with MACE (HR 1.92; 95% CI, 1.08–3.41; P =0.026) but not with recurrent stroke. Conclusions: Persistent high IBI trajectories were independently associated with recurrent stroke and MACE, and persistent high hs‐CRP trajectories were associated with MACE. Longitudinal assessment of inflammatory biomarkers may provide prognostic information beyond a single baseline measurement after ischemic stroke.
- Open Access
- 31 December 2025
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 17 (2) , 38-43
Clinical Characteristics and Early Outcomes of Stroke Revascularization in Cognitively Impaired Patients on Anti-dementia Medication
Background: Poor outcomes after acute ischemic stroke (AIS) revascularization are anticipated in patients with dementia due to advanced age, comorbidities, and reduced disease awareness. This study investigated clinical characteristics and short-term outcomes of AIS revascularization in patients undergoing dementia treatment.Methods: We retrospectively reviewed patients who underwent AIS revascularization therapy at eight centers of the Catholic University of Korea. Patients receiving anti-dementia medication for cognitive impairment before stroke onset were analyzed. Clinical characteristics and outcomes, including the modified Rankin Scale (mRS) score, hemorrhagic transformation, and mortality, were collected.Results: Among 1,379 patients who received AIS revascularization over 5 years, 13 (0.94%; mean age 83 years; 8 females) had a preexisting diagnosis of dementia (Alzheimer’s disease in 11, mild cognitive impairment in 2) and were on anti-dementia medication. Two patients underwent intravenous thrombolysis combined with endovascular therapy, whereas 11 underwent endovascular therapy alone. Most patients (11/13, 84.6%) presented with an unclear onset time. Stroke lesions were located in the right middle cerebral artery (MCA) in seven cases, left MCA in three, bilateral MCAs in one, and posterior circulation in two. Hemorrhagic transformation occurred in six patients (46%), of whom three (23%) were symptomatic. The mRS scores at discharge were 6 in two patients, 5 in one patient, 4 in nine patients, and 3 in one patient. Four patients died within 3 months of stroke onset.Conclusion: The proportion of patients with cognitive impairment receiving anti-dementia medication among those undergoing stroke revascularization therapy was very small. The rates of hemorrhagic transformation and mortality were high. None of the patients achieved favorable outcomes at discharge.
- 31 December 2025
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 17 (2) , 38-43
Open AccessClinical Characteristics and Early Outcomes of Stroke Revascularization in Cognitively Impaired Patients on Anti-dementia Medication
Background: Poor outcomes after acute ischemic stroke (AIS) revascularization are anticipated in patients with dementia due to advanced age, comorbidities, and reduced disease awareness. This study investigated clinical characteristics and short-term outcomes of AIS revascularization in patients undergoing dementia treatment.Methods: We retrospectively reviewed patients who underwent AIS revascularization therapy at eight centers of the Catholic University of Korea. Patients receiving anti-dementia medication for cognitive impairment before stroke onset were analyzed. Clinical characteristics and outcomes, including the modified Rankin Scale (mRS) score, hemorrhagic transformation, and mortality, were collected.Results: Among 1,379 patients who received AIS revascularization over 5 years, 13 (0.94%; mean age 83 years; 8 females) had a preexisting diagnosis of dementia (Alzheimer’s disease in 11, mild cognitive impairment in 2) and were on anti-dementia medication. Two patients underwent intravenous thrombolysis combined with endovascular therapy, whereas 11 underwent endovascular therapy alone. Most patients (11/13, 84.6%) presented with an unclear onset time. Stroke lesions were located in the right middle cerebral artery (MCA) in seven cases, left MCA in three, bilateral MCAs in one, and posterior circulation in two. Hemorrhagic transformation occurred in six patients (46%), of whom three (23%) were symptomatic. The mRS scores at discharge were 6 in two patients, 5 in one patient, 4 in nine patients, and 3 in one patient. Four patients died within 3 months of stroke onset.Conclusion: The proportion of patients with cognitive impairment receiving anti-dementia medication among those undergoing stroke revascularization therapy was very small. The rates of hemorrhagic transformation and mortality were high. None of the patients achieved favorable outcomes at discharge.
- Open Access
- 12 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (16) , 1754
Prognostic Value of Optic Nerve Sheath Diameters after Acute Ischemic Stroke According to Slice Thickness on Computed Tomography
The optic nerve sheath diameter (ONSD) can predict intracranial pressure and outcomes in neurological disease, but it remains unclear whether a small ONSD can be accurately measured on routine CT images with a slice thickness of approximately 4–5 mm. We measured the ONSD and ONSD/eyeball transverse diameter (ETD) ratio on routine-slice (4 mm) and thin-slice (0.6–0.75 mm) brain CT images from initial scans of acute ischemic stroke (AIS) patients. ONSD-related variables, National Institutes of Health Stroke Scale (NIHSS) scores, and age were compared between good (modified Rankin Scale [mRS] ≤ 2) and poor (mRS > 2) outcomes at discharge. Among 155 patients, 38 had poor outcomes. The thin-slice ONSD was different between outcome groups (p = 0.047), while the routine-slice ONSD showed no difference. The area under the curve (AUC) values for the ONSD and ONSD/ETD were 0.58 (95% CI, 0.49–0.66) and 0.58 (95% CI, 0.50–0.66) on the routine-slice CT, and 0.60 (95% CI, 0.52–0.68) and 0.62 (95% CI, 0.54–0.69) on the thin-slice CT. The thin-slice ONSD/ETD ratio correlated with initial NIHSS scores (r = 0.225, p = 0.005). After adjusting for NIHSS scores and age, ONSD-related variables were not associated with outcomes, and adding them to a model with NIHSS scores and age did not improve performance (all p-values > 0.05). Although ONSD measurements were not an independent outcome predictor, they correlated with stroke severity, and the thin-slice ONSD provided a slightly better prognostic performance than the routine-slice ONSD.
- 12 August 2024
- Published by MDPI AG in Diagnostics
- Vol. 14 (16) , 1754
Open AccessPrognostic Value of Optic Nerve Sheath Diameters after Acute Ischemic Stroke According to Slice Thickness on Computed Tomography
The optic nerve sheath diameter (ONSD) can predict intracranial pressure and outcomes in neurological disease, but it remains unclear whether a small ONSD can be accurately measured on routine CT images with a slice thickness of approximately 4–5 mm. We measured the ONSD and ONSD/eyeball transverse diameter (ETD) ratio on routine-slice (4 mm) and thin-slice (0.6–0.75 mm) brain CT images from initial scans of acute ischemic stroke (AIS) patients. ONSD-related variables, National Institutes of Health Stroke Scale (NIHSS) scores, and age were compared between good (modified Rankin Scale [mRS] ≤ 2) and poor (mRS > 2) outcomes at discharge. Among 155 patients, 38 had poor outcomes. The thin-slice ONSD was different between outcome groups (p = 0.047), while the routine-slice ONSD showed no difference. The area under the curve (AUC) values for the ONSD and ONSD/ETD were 0.58 (95% CI, 0.49–0.66) and 0.58 (95% CI, 0.50–0.66) on the routine-slice CT, and 0.60 (95% CI, 0.52–0.68) and 0.62 (95% CI, 0.54–0.69) on the thin-slice CT. The thin-slice ONSD/ETD ratio correlated with initial NIHSS scores (r = 0.225, p = 0.005). After adjusting for NIHSS scores and age, ONSD-related variables were not associated with outcomes, and adding them to a model with NIHSS scores and age did not improve performance (all p-values > 0.05). Although ONSD measurements were not an independent outcome predictor, they correlated with stroke severity, and the thin-slice ONSD provided a slightly better prognostic performance than the routine-slice ONSD.
- Open Access
Eccentric Vessel Wall Enhancement and hs-CRP as Prognostic Markers in Acute Ischemic Stroke: A Prospective Cohort Study
Background and Purpose Eccentric vessel wall enhancement (EVWE) and high-sensitivity C-reactive protein (hs-CRP) are inflammatory biomarkers associated with atherosclerotic disease. We investigated their prognostic value in patients with acute ischemic stroke receiving guideline-adherent medical treatment. Methods In this prospective observational cohort study, patients with acute non-cardioembolic ischemic stroke underwent vessel wall MRI and hs-CRP testing. The primary outcome was subsequent ischemic stroke during the follow-up period. The median follow-up duration was 21 months. Kaplan-Meier survival and Cox regression analysis was used to determine the associations between EVWE, hs-CRP levels, and subsequent ischemic stroke. Results Among 191 patients, 81 (42.4%) had EVWE. EVWE positivity showed a trend towards a lower risk of subsequent ischemic stroke compared to EVWE negativity (HR 0.32, 95% CI 0.12-0.87; P=0.061). Hs-CRP levels were not significantly associated with recurrent stroke risk. The combination of EVWE positivity and low hs-CRP levels (Conclusions In patients with acute ischemic stroke receiving optimal medical therapy, EVWE positivity may paradoxically indicate a lower risk of recurrent stroke. The combination of EVWE and hs-CRP status provides prognostic information, with EVWE positivity and low hs-CRP levels associated with the most favorable outcome. These findings highlight the potential role of integrating imaging and serum inflammatory biomarkers in risk stratification and management of acute ischemic stroke patients.
Open AccessEccentric Vessel Wall Enhancement and hs-CRP as Prognostic Markers in Acute Ischemic Stroke: A Prospective Cohort Study
Background and Purpose Eccentric vessel wall enhancement (EVWE) and high-sensitivity C-reactive protein (hs-CRP) are inflammatory biomarkers associated with atherosclerotic disease. We investigated their prognostic value in patients with acute ischemic stroke receiving guideline-adherent medical treatment. Methods In this prospective observational cohort study, patients with acute non-cardioembolic ischemic stroke underwent vessel wall MRI and hs-CRP testing. The primary outcome was subsequent ischemic stroke during the follow-up period. The median follow-up duration was 21 months. Kaplan-Meier survival and Cox regression analysis was used to determine the associations between EVWE, hs-CRP levels, and subsequent ischemic stroke. Results Among 191 patients, 81 (42.4%) had EVWE. EVWE positivity showed a trend towards a lower risk of subsequent ischemic stroke compared to EVWE negativity (HR 0.32, 95% CI 0.12-0.87; P=0.061). Hs-CRP levels were not significantly associated with recurrent stroke risk. The combination of EVWE positivity and low hs-CRP levels (Conclusions In patients with acute ischemic stroke receiving optimal medical therapy, EVWE positivity may paradoxically indicate a lower risk of recurrent stroke. The combination of EVWE and hs-CRP status provides prognostic information, with EVWE positivity and low hs-CRP levels associated with the most favorable outcome. These findings highlight the potential role of integrating imaging and serum inflammatory biomarkers in risk stratification and management of acute ischemic stroke patients.
- 2 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e387-e396
Acute Ischemic Stroke Caused by Internal Carotid Artery Occlusion: Impact of Occlusion Type on the Prognosis
- 2 May 2022
- Published by Elsevier in World Neurosurgery
- Vol. 164, e387-e396
Acute Ischemic Stroke Caused by Internal Carotid Artery Occlusion: Impact of Occlusion Type on the Prognosis
- 2 February 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (4) , 106328
Simultaneously Occurring Ischemic Stroke, Leg Artery Occlusion, and Pulmonary Embolism Induced by a Uterine Myoma
- 2 February 2022
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 31 (4) , 106328
Simultaneously Occurring Ischemic Stroke, Leg Artery Occlusion, and Pulmonary Embolism Induced by a Uterine Myoma
- Open Access
- 1 January 2021
- Published by XMLink in Journal of Clinical Neurology
- Vol. 17 (3) , 344-353
Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study
Hong KS, et al. J Clin Neurol. 2021 Jul;17(3):344-353. https://doi.org/10.3988/jcn.2021.17.3.344
- 1 January 2021
- Published by XMLink in Journal of Clinical Neurology
- Vol. 17 (3) , 344-353
Open AccessFimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study
Hong KS, et al. J Clin Neurol. 2021 Jul;17(3):344-353. https://doi.org/10.3988/jcn.2021.17.3.344
- Open Access
- 31 December 2019
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 11 (2) , 149-153
Bilateral PICA Territory Infarcts of Right Lateral Medulla and Left Cerebellum via Spontaneous Common PICA Dissection
- 31 December 2019
- Published by Korean Society of Neurosonology in Journal of Neurosonology and Neuroimaging
- Vol. 11 (2) , 149-153
Open AccessBilateral PICA Territory Infarcts of Right Lateral Medulla and Left Cerebellum via Spontaneous Common PICA Dissection